Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI, CAS Ink SciFinder Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News

AMRI, CAS Ink SciFinder Agreement

CDMO commits to 5-year deal for the research service

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI has signed a 5-year agreement for SciFinder from CAS, a division of the American Chemical Society (ACS). This investment ensures that all AMRI researchers globally will continue to have access to SciFinder. SciFinder gives AMRI’s research team unlimited access to a CAS’ collection of scientific content, curated by CAS scientists.
 
“SciFinder is an important tool for our researchers, providing ready access to scientific literature necessary for us to conduct our R&D activities,” said Michael Trova, senior vice president, drug discovery, AMRI. “Investing in the same high-quality information tools on which our customers rely gives them confidence in our expertise and ability to deliver innovative solutions to their projects.”
 
SciFinder is used by innovators across commercial, academic, and government organizations around the globe to gain insight from the published scientific literature including journals, patents, chemical substances, reactions, properties and more.
 
“CAS values our partnership with AMRI and applauds the innovation successes they have achieved,” said Craig Stephens, chief customer officer, CAS. “We appreciate the continued confidence they have placed in SciFinder with this long-term commitment and look forward to helping them continue providing exceptional results to their clients for years to come.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics